InnovAge Holding Corp. (INNV)
INNV trades on Nasdaq in Health Care, Medical/Nursing Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2026-06-30, https://www.sec.gov/Archives/edgar/data/1834376/000183437626000049/0001834376-26-000049-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-06-30.
Profile
| Field | Value |
|---|---|
| Ticker | INNV on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Nursing Services |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001834376 |
| SEC industry code | Services-Health Services |
| Incorporated in | DE |
Financials · 2026
| Line | Value |
|---|---|
| Revenue | $989.7M |
| Net income | -$2.5M |
| Operating income | $2.6M |
| Net margin | -0.3% |
| Operating margin | 0.3% |
| Revenue growth | +15.9% |
| Cash | $97.9M |
| Total assets | $557.4M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.3× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-03 |
| Cash and burn | $119.3M cash; operating cash flow $22.4M a quarter. | Report 2026-09-30 |
| Shares outstanding | 136,456,506 (2026-10-30); 135,681,431 a year earlier; 135,884,840 three years earlier. | Cover page 2026-10-30 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 0 424B5 takedowns | Latest 2026-07-31 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Deloitte & Touche LLP, Denver, Colorado, United States | PCAOB Form AP 2026-09-14 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $92.9M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q1 2027 2026-09-30 | $264.8M | $19.6M | $28.7M | $119.3M | $47.5M | $1.0B | 10-Q 2026-11-03 |
| Q4 2026 2026-06-30 | $262.0M | $8.3M | $21.3M | $97.9M | $48.8M | $989.7M | 10-K 2026-09-09 |
| Q3 2026 2026-03-31 | $251.9M | -$29.5M | $18.1M | $95.5M | $58.0M | $949.2M | 10-Q 2026-05-08 |
| Q2 2026 2025-12-31 | $239.7M | $10.6M | $21.4M | $83.2M | $58.5M | $915.4M | 10-Q 2026-02-03 |
| Q1 2026 2025-09-30 | $236.1M | $8.0M | $3.9M | $67.1M | $59.2M | $884.7M | 10-Q 2026-11-03 |
| Q4 2025 2025-06-30 | $221.4M | -$785K | $9.0M | $64.1M | $60.0M | $853.7M | 10-K 2026-09-09 |
| Q3 2025 2025-03-31 | $218.1M | -$11.4M | $24.6M | $60.5M | $62.7M | $831.7M | 10-Q 2026-05-08 |
| Q2 2025 2024-12-31 | $209.0M | -$13.2M | $6.8M | $46.1M | $63.6M | $806.6M | 10-Q 2026-02-03 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2026-09-24 |
| Latest annual report | 10-K | 2026-09-09 |
| Latest quarterly / interim | 10-Q | 2026-11-03 |
| Latest current report | 8-K | 2026-11-03 |
| Latest proxy | DEFA14A | 2026-10-22 |
Source: SEC EDGAR submissions feed, 272 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +5.6% |
| 1 month | +5.0% |
| 3 months | -11.1% |
| Year to date | +82.5% |
| 1 year | +76.7% |
| From 52-week high | -21.8% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Nursing Services
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PNTG | The Pennant Group Inc. Common Stock | $37.03 | +2.66% | $1.3B |
| USPH | U.S. Physical Therapy Inc. | $99.55 | +0.41% | $1.5B |
| WGS | GeneDx Holdings Corp. | $51.02 | -2.58% | $1.5B |
| TDOC | Teladoc Health Inc. | $8.70 | -1.14% | $1.6B |
| AHCO | AdaptHealth Corp. | $7.73 | +0.91% | $1.1B |
| OMDA | Omada Health Inc. | $14.49 | +1.12% | $898.9M |
| ADUS | Addus HomeCare Corporation | $124.61 | +1.31% | $2.3B |
| AVAH | Aveanna Healthcare Holdings Inc. | $11.63 | +1.13% | $2.5B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier